For people and their companion animals, enthusiasm for CBDenhanced products and medical applications far outruns evidence-based confirmation of their benefits. That is, however, slowly changing as legal hurdles to investigating the cannabinoid are becoming slightly less difficult to leap.
In late May, the FDA launched its first-ever hearing on CBD products with a long list of questions, including one of the most crucial: do they work? In the case of epilepsy—both human and canine—recent studies indi- cate the answer is yes.
Tags:
from The Bark https://ift.tt/2NSIrCq https://ift.tt/2MR8DxU
No comments:
Post a Comment